{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:11:15Z","timestamp":1723939875584},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,17]]},"DOI":"10.7759\/cureus.67078","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T16:14:30Z","timestamp":1723911270000},"source":"Crossref","is-referenced-by-count":0,"title":["Ophthalmologic Implications of Connective Tissue Diseases: A Comprehensive Review of Current Knowledge and Innovations"],"prefix":"10.7759","author":[{"given":"Yuga B","family":"Pawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana R","family":"Thool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier K","year":"2018","unstructured":"Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, Servettaz A. Autoantibodies associated with connective tissue diseases: what meaning for clinicians?. Front Immunol. 2018, 9:541. 10.3389\/fimmu.2018.00541","journal-title":"Front Immunol"},{"key":"ref2","article-title":"Mixed Connective Tissue Disease","author":"Sapkota B","year":"2024","unstructured":"Sapkota B, Al Khalili Y. Mixed Connective Tissue Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1874372200903010022","article-title":"Cutaneous connective tissue diseases: epidemiology, diagnosis, and treatment","volume":"3","author":"Reddy BY","year":"2009","unstructured":"Reddy BY, Hantash BM. Cutaneous connective tissue diseases: epidemiology, diagnosis, and treatment. Open Dermatol J. 2009, 3:22-31. 10.2174\/1874372200903010022","journal-title":"Open Dermatol J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2015.11.011","article-title":"Ocular involvement in cutaneous connective tissue disease","volume":"34","author":"Santoro FA","year":"2016","unstructured":"Santoro FA, Huang J. Ocular involvement in cutaneous connective tissue disease. Clin Dermatol. 2016, 34:138-45. 10.1016\/j.clindermatol.2015.11.011","journal-title":"Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_286_22","article-title":"Connective tissue disorders and eye: a review and recent updates","volume":"71","author":"Asif MI","year":"2023","unstructured":"Asif MI, Kalra N, Sharma N, Jain N, Sharma M, Sinha R. Connective tissue disorders and eye: a review and recent updates. Indian J Ophthalmol. 2023, 71:2385-98. 10.4103\/ijo.IJO_286_22","journal-title":"Indian J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino M","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013, 1:51-7. 10.1007\/s40135-013-0009-1","journal-title":"Curr Ophthalmol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050724","article-title":"The autoimmune rheumatic disease related dry eye and its association with retinopathy","volume":"13","author":"Shan H","year":"2023","unstructured":"Shan H, Liu W, Li Y, Pang K. The autoimmune rheumatic disease related dry eye and its association with retinopathy. Biomolecules. 2023, 13:724. 10.3390\/biom13050724","journal-title":"Biomolecules"},{"key":"ref8","article-title":"Dry eye syndrome","author":"Golden MI","year":"2024","unstructured":"Golden MI, Meyer JJ, Zeppieri M, Patel BC. Dry eye syndrome. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref9","article-title":"Episcleritis","author":"Schonberg S","year":"2024","unstructured":"Schonberg S, Stokkermans TJ. Episcleritis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref10","article-title":"Scleritis","author":"Lagina A","year":"2024","unstructured":"Lagina A, Ramphul K. Scleritis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref11","article-title":"Corneal Ulcer","author":"Byrd LB","year":"2024","unstructured":"Byrd LB, Gurnani B, Martin N. Corneal Ulcer. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref12","article-title":"Persistent Epithelial Defect","author":"Golhait P","year":"2024","unstructured":"Golhait P, Peseyie R. Persistent Epithelial Defect. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2016.02.001","article-title":"Ocular findings in systemic lupus erythematosus","volume":"30","author":"Shoughy SS","year":"2016","unstructured":"Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016, 30:117-21. 10.1016\/j.sjopt.2016.02.001","journal-title":"Saudi J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/290898","article-title":"Ocular manifestations of systemic lupus erythematosus: a review of the literature","volume":"2012","author":"Palejwala NV","year":"2012","unstructured":"Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012, 2012:290898. 10.1155\/2012\/290898","journal-title":"Autoimmune Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.58423","article-title":"Differential diagnosis of retinal vasculitis","volume":"16","author":"Abu El-Asrar AM","year":"2009","unstructured":"Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009, 16:202-18. 10.4103\/0974-9233.58423","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref16","article-title":"Systemic Lupus Erythematosus","author":"Justiz Vaillant AA","year":"2024","unstructured":"Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000768","article-title":"Optic Neuritis","volume":"25","author":"Bennett JL","year":"2019","unstructured":"Bennett JL. Optic Neuritis. Continuum (Minneap Minn). 2019, 25:1236-64. 10.1212\/CON.0000000000000768","journal-title":"Continuum (Minneap Minn)"},{"key":"ref18","article-title":"Sjogren Syndrome","author":"Carsons SE","year":"2024","unstructured":"Carsons SE, Patel BC. Sjogren Syndrome. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref19","unstructured":"Ophthalmologic manifestations of Sjogren syndrome. overview, etiology and pathophysiology, clinical evaluation. (2023). Accessed: April 26, 2024: https:\/\/emedicine.medscape.com\/article\/1192919-overview."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2017.8105","article-title":"MALT lymphoma of minor salivary glands in a Sj\u00f6gren's syndrome patient: a case report and review of literature","volume":"8","author":"Titsinides S","year":"2017","unstructured":"Titsinides S, Nikitakis N, Piperi E, Sklavounou A. MALT lymphoma of minor salivary glands in a Sj\u00f6gren's syndrome patient: a case report and review of literature. J Oral Maxillofac Res. 2017, 8:e5. 10.5037\/jomr.2017.8105","journal-title":"J Oral Maxillofac Res"},{"key":"ref21","article-title":"Systemic Sclerosis (Scleroderma)","author":"Adigun R","year":"2024","unstructured":"Adigun R, Goyal A, Hariz A. Systemic Sclerosis (Scleroderma). StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744396","article-title":"Epidemiology of ocular manifestations in autoimmune disease","volume":"12","author":"Glover K","year":"2021","unstructured":"Glover K, Mishra D, Singh TR. Epidemiology of ocular manifestations in autoimmune disease. Front Immunol. 2021, 12:744396. 10.3389\/fimmu.2021.744396","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/life14050627","article-title":"Ocular manifestation in systemic sclerosis-a Literature review","volume":"14","author":"Paczwa K","year":"2024","unstructured":"Paczwa K, Rerych M, Romanowska-Pr\u00f3chnicka K, R\u00f3\u017cycki R, Go\u0142\u0119biewska J. Ocular manifestation in systemic sclerosis-a Literature review. Life (Basel). 2024, 14:627. 10.3390\/life14050627","journal-title":"Life (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2021.103436","article-title":"Prevalence of retinal changes in patients with systemic sclerosis: the association between retinal vascular changes and nailfold capillaroscopic findings","volume":"59","author":"Shenavandeh S","year":"2021","unstructured":"Shenavandeh S, Afarid M, Hasanaghaei T, Nazarinia MA. Prevalence of retinal changes in patients with systemic sclerosis: the association between retinal vascular changes and nailfold capillaroscopic findings. Reumatologia. 2021, 59:27-34. 10.5114\/reum.2021.103436","journal-title":"Reumatologia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322011000300003","article-title":"Ocular findings in patients with systemic sclerosis","volume":"66","author":"Gomes Bde A","year":"2011","unstructured":"Gomes Bde A, Santhiago MR, Magalh\u00e3es P, Kara-Junior N, Azevedo MN, Moraes HV Jr. Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 2011, 66:379-85. 10.1590\/s1807-59322011000300003","journal-title":"Clinics (Sao Paulo)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb RN","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014, 311:1901-11. 10.1001\/jama.2014.3192","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_510_15","article-title":"Evaluation of red flags minimizes missing serious diseases in primary care","volume":"7","author":"Ramanayake RP","year":"2018","unstructured":"Ramanayake RP, Basnayake BM. Evaluation of red flags minimizes missing serious diseases in primary care. J Family Med Prim Care. 2018, 7:315-8. 10.4103\/jfmpc.jfmpc_510_15","journal-title":"J Family Med Prim Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16638-0_3","article-title":"Optical coherence tomography (OCT): principle and technical realization","author":"Aumann S","year":"2019","unstructured":"Aumann S, Donner S, Fischer J, M\u00fcller F. Optical coherence tomography (OCT): principle and technical realization. High Resolution Imaging in Microscopy and Ophthalmology.  Bille J (ed): Springer, Cham; 2019. 10.1007\/978-3-030-16638-0_3"},{"key":"ref29","article-title":"Fluorescein Angiography","author":"Ruia S","year":"2024","unstructured":"Ruia S, Tripathy K. Fluorescein Angiography. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited","volume":"4","author":"Kumar Y","year":"2009","unstructured":"Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol. 2009, 4:1. 10.1186\/1746-1596-4-1","journal-title":"Diagn Pathol"},{"key":"ref31","article-title":"Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine","volume":"115","author":"Bray C","year":"2016","unstructured":"Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016, 115:317-21.","journal-title":"WMJ"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjo.2015.03.004","article-title":"Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention","volume":"5","author":"Hornbeak DM","year":"2015","unstructured":"Hornbeak DM, Thorne JE. Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol. 2015, 5:156-63. 10.1016\/j.tjo.2015.03.004","journal-title":"Taiwan J Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00767-0","article-title":"Shaping the future of Beh\u00e7et's uveitis management: a comprehensive review of efficacy, challenges, and prospects of biologic therapies","volume":"12","author":"Li B","year":"2023","unstructured":"Li B, Li H, Huang Q, Zheng Y. Shaping the future of Beh\u00e7et's uveitis management: a comprehensive review of efficacy, challenges, and prospects of biologic therapies. Ophthalmol Ther. 2023, 12:2295-321. 10.1007\/s40123-023-00767-0","journal-title":"Ophthalmol Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/OPTO.S350185","article-title":"Artificial tears: a systematic review","volume":"15","author":"Semp DA","year":"2023","unstructured":"Semp DA, Beeson D, Sheppard AL, Dutta D, Wolffsohn JS. Artificial tears: a systematic review. Clin Optom (Auckl). 2023, 15:9-27. 10.2147\/OPTO.S350185","journal-title":"Clin Optom (Auckl)"},{"key":"ref35","article-title":"Cataract Surgery","author":"Moshirfar M","year":"2024","unstructured":"Moshirfar M, Milner D, Patel BC. Cataract Surgery. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-199903910-00011","article-title":"Scleral patch graft in the management of necrotizing scleritis","volume":"39","author":"Nguyen QD","year":"1999","unstructured":"Nguyen QD, Foster CS. Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin. 1999, 39:109-31. 10.1097\/00004397-199903910-00011","journal-title":"Int Ophthalmol Clin"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814168","article-title":"Advances in molecular medicine: unravelling disease complexity and pioneering precision healthcare","volume":"24","author":"Bustin SA","year":"2023","unstructured":"Bustin SA, Jellinger KA. Advances in molecular medicine: unravelling disease complexity and pioneering precision healthcare. Int J Mol Sci. 2023, 24:14168. 10.3390\/ijms241814168","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-017-0688-8","article-title":"Diseases and molecular diagnostics: a step closer to precision medicine","volume":"32","author":"Dwivedi S","year":"2017","unstructured":"Dwivedi S, Purohit P, Misra R, et al.. Diseases and molecular diagnostics: a step closer to precision medicine. Indian J Clin Biochem. 2017, 32:374-98. 10.1007\/s12291-017-0688-8","journal-title":"Indian J Clin Biochem"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55315","article-title":"The role of point-of-care testing to improve acute care and health care services","volume":"16","author":"Elrobaa IH","year":"2024","unstructured":"Elrobaa IH, Khan K, Mohamed E. The role of point-of-care testing to improve acute care and health care services. Cureus. 2024, 16:e55315. 10.7759\/cureus.55315","journal-title":"Cureus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12010009","article-title":"Anti-idiotypic mRNA vaccine to treat autoimmune disorders","volume":"12","author":"Niazi SK","year":"2023","unstructured":"Niazi SK. Anti-idiotypic mRNA vaccine to treat autoimmune disorders. Vaccines (Basel). 2023, 12:9. 10.3390\/vaccines12010009","journal-title":"Vaccines (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi M","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQ, et al.. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023, 22:169. 10.1186\/s12943-023-01865-0","journal-title":"Mol Cancer"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR gene therapy: applications, limitations, and implications for the future","volume":"10","author":"Uddin F","year":"2020","unstructured":"Uddin F, Rudin CM, Sen T. CRISPR gene therapy: applications, limitations, and implications for the future. Front Oncol. 2020, 10:1387. 10.3389\/fonc.2020.01387","journal-title":"Front Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2024.04.023","article-title":"Progress in organ bioprinting for regenerative medicine\u2014article","volume":"16","author":"Wang X","year":"2024","unstructured":"Wang X, Zhang D, Pratap Singh Y, et al.. Progress in organ bioprinting for regenerative medicine\u2014article. Engineering. 2024, 16:3389. 10.1016\/j.eng.2024.04.023","journal-title":"Engineering"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.02.045","article-title":"Interdisciplinary diagnosis and management of patients with interstitial lung disease and connective tissue disease","volume":"166","author":"Guler SA","year":"2024","unstructured":"Guler SA, Scheschkowski T, Renner A, K\u00e4mpf L, Gasser M, Maurer B. Interdisciplinary diagnosis and management of patients with interstitial lung disease and connective tissue disease. Chest. 2024, 166:352-61. 10.1016\/j.chest.2024.02.045","journal-title":"Chest"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16468.1","article-title":"What's new in dry eye disease diagnosis? Current advances and challenges","volume":"7","author":"Aggarwal S","year":"2018","unstructured":"Aggarwal S, Galor A. What's new in dry eye disease diagnosis? Current advances and challenges. F1000Res. 2018, 7:F1000 Faculty Rev-1952. 10.12688\/f1000research.16468.1","journal-title":"F1000Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20020954","article-title":"The significance of cooperation in interdisciplinary health care teams as perceived by Polish medical students","volume":"20","author":"Bendowska A","year":"2023","unstructured":"Bendowska A, Baum E. The significance of cooperation in interdisciplinary health care teams as perceived by Polish medical students. Int J Environ Res Public Health. 2023, 20:954. 10.3390\/ijerph20020954","journal-title":"Int J Environ Res Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285471-ophthalmologic-implications-of-connective-tissue-diseases-a-comprehensive-review-of-current-knowledge-and-innovations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T16:14:34Z","timestamp":1723911274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285471-ophthalmologic-implications-of-connective-tissue-diseases-a-comprehensive-review-of-current-knowledge-and-innovations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.67078","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,17]]}}}